This document is an equity research report by J.P. Morgan on Bristol-Myers Squibb Company, providing a model update and establishing a 2016 price target of $78. It includes financial data, investment thesis, valuation, risks, and analyst certification. The report also contains detailed financial tables and disclosures.
documents/EFTA01087643.pdf
{}